AGL as reported
agilon health, inc. reported $5.82B of revenue over the trailing twelve months, −2.8% on the year before. 9 reported series are charted on this page, each one as filed.
$5.82B
Revenue, trailing twelve months · to Q1 2026 · −2.8% against the twelve months before
- Net Income
- −$355M
Net Income · +47% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- −$63M
Free Cash Flow · +12% year on year · trailing twelve months to Q1 2026
- Op Margin
- −7.4%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $5.82B | −2.8% | Q1 2026 |
| Net Income | −$355M | +47% | Q1 2026 |
| EPS | $1.96 | +1682% | Q1 2026 |
| Op Margin | −7.4% | n/a | Q1 2026 |
| Net Margin | −5.9% | n/a | Q1 2026 |
| ROE | −171% | n/a | Q1 2026 |
| ROA | −23% | n/a | Q1 2026 |
| ROIC | 571% | n/a | Q1 2026 |
| Free Cash Flow | −$63M | +12% | Q1 2026 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
agilon health, inc. (AGL) - Revenue & ProfitRevenue & Profitagilon health, inc. (AGL)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com